» Articles » PMID: 21574025

The Puzzling Clinical Spectrum and Course of Juvenile Sarcoidosis

Overview
Journal World J Pediatr
Specialty Pediatrics
Date 2011 May 17
PMID 21574025
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Juvenile sarcoidosis is a rare, chronic, multisystem, granulomatous disease of obscure etiology which is seen in childhood and adulthood. The disease in childhood has a course different from that in adulthood.

Data Sources: PubMed database was searched using terms sarcoidosis, children or childhood sarcoidosis or juvenile sarcoidosis in combination with one of the following terms: epidemiology, clinical manifestations, genetics, diagnosis, treatment, and prognosis. We also retrieved the terms such as early onset sarcoidosis and Blau syndrome. Furthermore, e-medicine and European Respiratory Society monographs for sarcoidosis were reviewed.

Results: Sarcoidosis in childhood presents with two age dependent, distinct forms. In younger children it is clinically evident before the age of four years and characterized by the triad of rash, arthritis and uveitis. In their older counterparts, the juvenile late onset sarcoidosis involves several organs and its clinical appearance resembles the adult type of the disease, with the respiratory system being most frequently affected (hilar lymphadenopathy, pulmonary infiltrations). Steroid is the main agent of treatment whereas methotrexate is also used for beneficial steroid sparing effects. New, novel therapies may change the outcome of the disease especially in difficult morbid cases.

Conclusions: Sarcoidosis in childhood is recognized as a systemic disease affecting various organs and having diverse clinical course depending on the age of onset.

Citing Articles

Potential Benefits of TNF Targeting Therapy in Blau Syndrome, a NOD2-Associated Systemic Autoinflammatory Granulomatosis.

Matsuda T, Kambe N, Takimoto-Ito R, Ueki Y, Nakamizo S, Saito M Front Immunol. 2022; 13:895765.

PMID: 35711422 PMC: 9195515. DOI: 10.3389/fimmu.2022.895765.


Hypercalcemia, an Important Puzzle Piece in Uncommon Onset Pediatric Sarcoidosis-A Case Report and a Review of the Literature.

Marginean C, Melit L, Grigorescu G, Puiac C, Simu I Front Pediatr. 2020; 8:497.

PMID: 32984210 PMC: 7479091. DOI: 10.3389/fped.2020.00497.


Bone marrow involvement: Atypical presentation of early-onset childhood sarcoidosis.

Meshram R, Gajimwar V, Gholap S, Jhanwar M Eur J Rheumatol. 2020; .

PMID: 32910768 PMC: 7574765. DOI: 10.5152/eurjrheum.2020.20076.


Chest Imaging of a rare case of cat-scratch disease in a 2-years-old baby.

Rossi E, Perrone A, Bongini U, Cangelosi A, Sollai S, Narese D Acta Biomed. 2019; 89(4):585-588.

PMID: 30657130 PMC: 6502092. DOI: 10.23750/abm.v89i4.6070.


[Ocular sarcoidosis].

Springer-Wanner C, Brauns T Z Rheumatol. 2017; 76(5):391-397.

PMID: 28516270 DOI: 10.1007/s00393-017-0303-7.


References
1.
Fink C, Cimaz R . Early onset sarcoidosis: not a benign disease. J Rheumatol. 1997; 24(1):174-7. View

2.
Marcille R, McCarthy M, Barton J, Merten D, Spock A . Long-term outcome of pediatric sarcoidosis with emphasis on pulmonary status. Chest. 1992; 102(5):1444-9. DOI: 10.1378/chest.102.5.1444. View

3.
Beneteau-Burnat B, Baudin B, Morgant G, Baumann F, Giboudeau J . Serum angiotensin-converting enzyme in healthy and sarcoidotic children: comparison with the reference interval for adults. Clin Chem. 1990; 36(2):344-6. View

4.
Grutters J, Sato H, Welsh K, du Bois R . The importance of sarcoidosis genotype to lung phenotype. Am J Respir Cell Mol Biol. 2003; 29(3 Suppl):S59-62. View

5.
Ishihara M, Ohno S, Ono H, Isogai E, Kimura K, Isogai H . Seroprevalence of anti-Borrelia antibodies among patients with confirmed sarcoidosis in a region of Japan where Lyme borreliosis is endemic. Graefes Arch Clin Exp Ophthalmol. 1998; 236(4):280-4. DOI: 10.1007/s004170050078. View